awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41386664-AD272F55-847E-46A8-ACE9-D680E7EAA82D
Q41386664-AD272F55-847E-46A8-ACE9-D680E7EAA82D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41386664-AD272F55-847E-46A8-ACE9-D680E7EAA82D
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
P1476
Q41386664-AD272F55-847E-46A8-ACE9-D680E7EAA82D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41386664-AD272F55-847E-46A8-ACE9-D680E7EAA82D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80010b3a2d7be4b4b250900102dbb38e12bd458a
P1476
Natalizumab discontinuation in
......
fits at therapeutic crossroads
@en